These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3390157)

  • 1. Biochemical measurements in Alzheimer's disease reveal a necessity for improved neuroimaging techniques to study metabolism.
    Najlerahim A; Bowen DM
    Biochem J; 1988 Apr; 251(1):305-8. PubMed ID: 3390157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease.
    Hansen LA; DeTeresa R; Davies P; Terry RD
    Neurology; 1988 Jan; 38(1):48-54. PubMed ID: 3336463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism.
    Tamminga CA; Foster NL; Fedio P; Bird ED; Chase TN
    Neurology; 1987 Jan; 37(1):161-5. PubMed ID: 2879258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain choline acetyltransferase activity and neuropeptide Y concentrations in Alzheimer's disease.
    Foster NL; Tamminga CA; O'Donohue TL; Tanimoto K; Bird ED; Chase TN
    Neurosci Lett; 1986 Jan; 63(1):71-5. PubMed ID: 3754039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralaminar distribution of neurotransmitter-related enzymes in cerebral cortex of Alzheimer's disease.
    Sorbi S; Piacentini S; Amaducci L
    Gerontology; 1987; 33(3-4):197-202. PubMed ID: 3653702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
    Pearce BR; Palmer AM; Bowen DM; Wilcock GK; Esiri MM; Davison AN
    Neurochem Pathol; 1984-1985 Winter; 2(4):221-32. PubMed ID: 6085697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.
    Lowe SL; Francis PT; Procter AW; Palmer AM; Davison AN; Bowen DM
    Brain; 1988 Aug; 111 ( Pt 4)():785-99. PubMed ID: 3401683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topographical distribution of neurochemical changes in Alzheimer's disease.
    Procter AW; Lowe SL; Palmer AM; Francis PT; Esiri MM; Stratmann GC; Najlerahim A; Patel AJ; Hunt A; Bowen DM
    J Neurol Sci; 1988 Apr; 84(2-3):125-40. PubMed ID: 2898011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease.
    Bowen DM; Davison AN
    Br Med Bull; 1986 Jan; 42(1):75-80. PubMed ID: 2869819
    [No Abstract]   [Full Text] [Related]  

  • 10. Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies.
    Slotkin TA; Nemeroff CB; Bissette G; Seidler FJ
    J Clin Invest; 1994 Aug; 94(2):696-702. PubMed ID: 8040324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]Kainic acid binding and choline acetyltransferase activity in Alzheimer's dementia.
    Pearce BR; Bowen DM
    Brain Res; 1984 Sep; 310(2):376-8. PubMed ID: 6488028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
    Bird TD; Stranahan S; Sumi SM; Raskind M
    Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of neurotransmitter abnormalities in Alzheimer's disease.
    Katzman R; Brown T; Fuld P; Thal L; Davies P; Terry R
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():279-86. PubMed ID: 2873637
    [No Abstract]   [Full Text] [Related]  

  • 14. Alzheimer's disease: a correlative study.
    Neary D; Snowden JS; Mann DM; Bowen DM; Sims NR; Northen B; Yates PO; Davison AN
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):229-37. PubMed ID: 2420941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.
    Bowen DM; Najlerahim A; Procter AW; Francis PT; Murphy E
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9504-8. PubMed ID: 2574463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choline in Alzheimer's disease.
    Spillane JA; Goodhart MJ; White P; Bowen DM; Davison AN
    Lancet; 1977 Oct; 2(8042):826-7. PubMed ID: 71636
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus.
    Allen SJ; MacGowan SH; Treanor JJ; Feeney R; Wilcock GK; Dawbarn D
    Neurosci Lett; 1991 Sep; 131(1):135-9. PubMed ID: 1791973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
    CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.
    Schöll M; Ossenkoppele R; Strandberg O; Palmqvist S; ; Jögi J; Ohlsson T; Smith R; Hansson O
    Brain; 2017 Sep; 140(9):2286-2294. PubMed ID: 29050382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
    Wilcock GK; Esiri MM; Bowen DM; Hughes AO
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):842-9. PubMed ID: 3404192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.